Consumer Marketing briefs

Share this article:
Merck's Schering-Plough HealthCare Products launched Zegerid OTC with a consumer campaign featuring a body-painting motif, suggestive of the PPI's coating action, and the tagline “Discover the difference.” Merck is licensing marketing rights for the OTC switch from Santarus. Professional efforts are focusing on about 45,000 physicians who prescribe PPIs but are not reached by Santarus reps.

Michael Durand joined London-based Resolute Communications as managing director of its New York office. Durand, who was a founding director of Porter Novelli's global healthcare practice, where he spent 21 years and launched blockbusters like BMS' Glucophage, Merck's Vytorin and Sanofi-Aventis' Taxotere. He also served as managing director of healthcare strategy and planning for Ogilvy PR Worldwide.

Shire's launch of its new corporate brand, dubbed “Brave,” was named Employee Communications Campaign of the Year by MM&M's sister title, PRWeek. The Shire effort beat out campaigns by GE, Molson Coors, Harrah's and Novartis Oncology.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...